[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355633-105":59,"doc-detail-355633-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sensitive-detection-of-somatic-mutations-in-gc-rich-cancer-gene-promoters","Sensitive detection of somatic mutations in GC-rich cancer gene promoters","","Somatic mutations in protein-coding genes and noncoding regulatory regions drive cancer, yet only a limited set of noncoding driver mutations has been identified so far, including promoter alterations in TERT, FOXA1, and TP53. Promoter impacts can strongly initiate, increase, or abolish gene expression, but promoter mutations remain difficult to detect from whole-tumor genomes because GC-rich sequences cause loss of sequencing coverage. A hybrid capture assay was developed and optimized for >3000 cancer gene promoters, enabling deep sequencing of GC-rich regions and reliable discovery of point mutations, short indels, CNVs, and mutational signatures in cell lines and archival tissues. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sensitive-detection-of-somatic-mutations-in-gc-rich-cancer-gene-promoters/355633/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sensitive-detection-of-somatic-mutations-in-gc-rich-cancer-gene-promoters/355633.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are somatic promoter mutations in GC-rich regions difficult to detect from whole tumor genomes?","Question",{"text":112,"@type":113},"GC-rich promoter DNA is amplified less efficiently during library preparation, leading to dropout and uneven or missing sequencing coverage. This creates “blind spots” that can cause missed mutation calls.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the main approach presented in the document?",{"text":117,"@type":113},"A hybrid capture assay optimized for more than 3000 cancer gene promoters is used to enable deep sequencing of challenging GC-rich regions.",{"name":119,"@type":110,"acceptedAnswer":120},"What kinds of genomic alterations can the assay identify?",{"text":121,"@type":113},"The assay supports discovery of reliable point mutations, short insertions and deletions, copy number variants, and mutational signatures in both cell line models and formalin-fixed, paraffin-embedded archival tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355633,1790363160,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","NAR Cancer, 2026, 8, zcag011  \n[https://doi.org/10.1093/narcan/zcag011](https://doi.org/10.1093/narcan/zcag011)  \nCancer Genomics  \nSensitive detection of somatic mutations in GC-rich cancer gene promoters  \nMeifang Qi1,2,3,4 ,* ,†, Preshita Sanjay Dave1,2,3 ,†, Nicole Francis3,5 , Matthew DeFelice3,5 , Sam Pollock3,5 , Holly Corbitt6 , Irene Rin Mitsiades1,2,3, Gengchao Wang1,2,3, Paul Frere6 , Alan Fox6 , Gregory Khitrov6 , Caroline Petersen3,5 , Katie Larkin3,5 , Susanna Hamilton3,5 , Leif W. Ellisen1,2,7, Doga C. Gulhan1,2 , Alfredo Hidalgo-Miranda8 , Niall Lennon3,5 , Carrie Cibulskis3,5 ,* ,  \nEsther Rheinbay 1,2,3,9 ,* ,‡  \n1 Krantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129 Boston, MA, United States  \n2 Harvard Medical School Department of Medicine, Boston, MA 02115, United States  \n3 Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States  \n4 Present address: Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 200031 Shanghai, China  \n5 Broad Clinical Laboratories, LLC, Burlington, MA 01803, United States  \n6Twist Bioscience South San Francisco, California, CA 94080, United States  \n7 Ludwig Center at Harvard, Boston, MA 02115, United States  \n8 Laboratorio de Genomica del Cancer, Instituto Nacional de Medicina Genomica, Periferico Sur 4809, Arenal Tepepan, Mexico City 14610, Mexico  \n9 Massachusetts General Hospital Department of Pathology, Boston, MA 02114, United States  \n∗ To whom correspondence should be addressed. Email: [erheinbay@mgh.harvard.edu](erheinbay@mgh.harvard.edu)  \nCorrespondence may also be addressed to Carrie Cibuslkis. Email: [carrie@broadinstitute.org](carrie@broadinstitute.org)  \nCorrespondence may also be addressed [to Meifang Qi. Email:](to Meifang Qi. Email: mfqi@sinh.ac.cn)[ mfqi@sinh.ac.cn](to Meifang Qi. Email: mfqi@sinh.ac.cn)  \n†These authors contributed equally to this work.  \n‡ Lead contact.  \nAbstract  \nSomatic mutations in protein-coding genes and noncoding regulatory regions are the major drivers of cancer. Only a relatively small number of somatic noncoding mutations that are likely drivers have been described to date, including those in the promoters of the TERT, FOXA1 , and TP53 genes. The impact of these alterations can be profound by initiating , increasing , or abolishing gene expression. Promoter mutations in particular have been difficult to identify even from whole tumor genomes due to their high content of G and C nucleotides, which leads to loss of sequencing coverage in these regions. Therefore, the landscape of somatic drivers in gene promoters remains incomplete. Here, we present a hybrid capture assay optimized for >3000 promoters of cancer genes. We show that this assay allows for deep sequencing of challenging GC-rich promoter regions, enabling discovery of reliable point mutations, short insertions and deletions, copy number variants, and mutational signatures in cell line models as well as formalin-fixed, paraffin-embedded archival tissue samples. Our assay nominated candidate noncoding driver mutations in CDK4, SMAD3, and GATA3 in breast cancer for future functional follow-up.  \nGraphical abstract  \nReceived: November 5, 2025 . Revised: February 1, 2026 . Accepted: February 25, 2026  \n© The Author(s) 2026 . Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [reprints@oup.com](reprints@oup.com) for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for ","cbCaiizFlIvPoqWl","https://ap.wps.com/l/cbCaiizFlIvPoqWl","pdf",2454604,14,"English","# Abstract\n# Introduction","[{\"question\":\"Why are somatic promoter mutations in GC-rich regions difficult to detect from whole tumor genomes?\",\"answer\":\"GC-rich promoter DNA is amplified less efficiently during library preparation, leading to dropout and uneven or missing sequencing coverage. This creates “blind spots” that can cause missed mutation calls.\"},{\"question\":\"What is the main approach presented in the document?\",\"answer\":\"A hybrid capture assay optimized for more than 3000 cancer gene promoters is used to enable deep sequencing of challenging GC-rich regions.\"},{\"question\":\"What kinds of genomic alterations can the assay identify?\",\"answer\":\"The assay supports discovery of reliable point mutations, short insertions and deletions, copy number variants, and mutational signatures in both cell line models and formalin-fixed, paraffin-embedded archival tissues.\"}]","Sensitive detection of somatic mutations in GC-rich cancer gene promoters | PDF",1790120235,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f67b01d912da59289a3cdf98ff127bfa.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/425bfa3b953dba48dd41092acf249bed.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fda93132d02a9d612690949c77dec3b.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7a415cde270a148f94e031dcae34df7.webp",980,1268]